4//SEC Filing
Nisco James 4
Accession 0002020260-26-000003
CIK 0000320017other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 4:08 PM ET
Size
13.6 KB
Accession
0002020260-26-000003
Insider Transaction Report
Form 4
Nisco James
SVP, Fin/Treas, Chief Actg Off
Transactions
- Award
Common Stock
[F1][F2]2026-01-09+15,000→ 38,491 total - Tax Payment
Common Stock
[F3][F2]2026-01-09$1.97/sh−2,131$4,198→ 36,360 total - Tax Payment
Common Stock
[F3][F2]2026-01-09$1.97/sh−2,131$4,198→ 34,229 total - Tax Payment
Common Stock
[F3][F2]2026-01-09$1.97/sh−1,137$2,240→ 33,092 total - Tax Payment
Common Stock
[F3][F2]2026-01-09$1.97/sh−781$1,539→ 32,311 total - Award
Stock Option (Right to Buy)
[F4]2026-01-09+7,000→ 7,000 totalExercise: $1.97From: 2026-01-09Exp: 2036-01-09→ Common Stock (7,000 underlying)
Footnotes (4)
- [F1]Represents 15,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.
- [F2]Includes 20,750 unvested restricted stock.
- [F3]Shares withheld as payment of a tax liability on vesting of restricted stock.
- [F4]One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third anniversaries of the grant date.
Signature
James Nisco|2026-01-13
Documents
Issuer
LISATA THERAPEUTICS, INC.
CIK 0000320017
Entity typeother
Related Parties
1- filerCIK 0002020260
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 4:08 PM ET
- Size
- 13.6 KB